Alvio Pharmaceuticals Private Limited, a active private limited company, was established on 25 January 2008 in Sarkhej, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100GJ2008PTC092271. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.27 Cr.
Formerly known as Akshay Vyapaar Private Limited. It upholds a compliant status. Employing 171 professional, Its leadership includes Manish Kumar Dudhwewala (Whole-Time Director), Nilesh Kumar Dudhwewala (Whole-Time Director). Past directors included Manish Kumar Dudhwewala, Shyam Sunder Choudhary, Nilesh Kumar Dudhwewala. It holds ₹16.46 Cr open charges and ₹2.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 1003 Block D, 10Th Floor, Signature 2, Sarkhej Sanand Crossroad,, Sarkhej, Gujarat, 382210.
U24100GJ2008PTC092271
092271
25 January 2008
₹5.00 Cr
₹4.27 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Alvio Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Kumar Dudhwewala | Whole-Time Director | 07 Feb 2008 | Current |
| Nilesh Kumar Dudhwewala | Whole-Time Director | 07 Oct 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Dec 2015 | Past |
| Pramod Abcsdd | Director | 15 Nov 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 19 Oct 2015 | Past |
| Pramod Abcsdd | Director | 15 Nov 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alvio Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.05% decrease. The company also saw a substantial improvement in profitability, with a 248.7% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Alvio Pharmaceuticals had a promoter holding of 95.63% and a public holding of 4.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹164,615,000.00
₹2,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2025 | Others | ₹9.20 M | Open |
| 12 Oct 2023 | Others | ₹1.50 M | Open |
| 24 Feb 2022 | Others | ₹4.00 Cr | Open |
| 22 Feb 2022 | Others | ₹6.40 M | Open |
| 15 Dec 2021 | Others | ₹0.95 M | Open |
Explore comprehensive loan charge details -
Alvio Pharmaceuticals has a workforce of 171 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Alvio Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alvio Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 9.50 Cr registered on 11 Sep 2017 with Charge ID 100122846 was modified on 02 Jul 2025. was documented.
The activity A charge with Others amounted to Rs. 0.92 Cr with Charge ID 101056259 was registered on 31 Jan 2025. was completed.
Progress on Alvio Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Alvio Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Progress on A charge registered on 27 Apr 2020 via Charge ID 100360043 with Others was fully satisfied on 19 Dec 2023. was documented.
The activity A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100812361 was registered on 12 Oct 2023. was completed.
The CIN of Alvio Pharmaceuticals Private Limited is U24100GJ2008PTC092271.
Alvio Pharmaceuticals Private Limited is headquartered at Office No. 1003 Block D, 10Th Floor, Signature 2, Sarkhej Sanand Crossroad,, Sarkhej, Gujarat, 382210.
Alvio Pharmaceuticals Private Limited was incorporated on 25 January 2008.
The current directors of Alvio Pharmaceuticals Private Limited are
The primary industry of Alvio Pharmaceuticals Private Limited is Trade.
Alvio Pharmaceuticals Private Limited is unlisted.
The authorized capital of Alvio Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.27 Cr.
The compliance status of Alvio Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX